- Home
- PPBT vs PAVM Comparison
PPBT vs PAVM Comparison
Compare PPBT & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PPBT | PAVM |
|---|---|---|
| Founded | 2010 | 2014 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4M | 41.1M |
| IPO Year | 2014 | 2015 |
Fundamental Metrics
Financial Performance| Metric | PPBT | PAVM |
|---|---|---|
| Price | $1.48 | $3.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $30.00 | ★ $65.00 |
| AVG Volume (30 Days) | ★ 2.1M | 22.8K |
| Earning Date | 05-20-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,000,000.00 |
| Revenue This Year | N/A | $603.94 |
| Revenue Next Year | N/A | $33.16 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.00 |
| 52 Week Low | $0.41 | $0.21 |
| 52 Week High | $5.18 | $28.44 |
Technical Indicators
Market Signals| Indicator | PPBT | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 40.50 | N/A |
| Support Level | $1.35 | N/A |
| Resistance Level | $1.85 | N/A |
| Average True Range (ATR) | 0.18 | 0.00 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 16.77 | 0.00 |
Price Performance
Historical ComparisonAbout PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.